INTERNATIONAL PATENT: JOSLIN DIABETES CENTER FILES APPLICATION FOR "MODIFIED STEM CELLS MATCHED TO PATIENT HLA TYPE"

GENEVA, Nov. 5 -- JOSLIN DIABETES CENTER (One Joslin PlaceBoston, Massachusetts 02215) filed a patent application (PCT/US2025/025926) for "MODIFIED STEM CELLS MATCHED TO PATIENT HLA TYPE" on Apr 23, 2025. With publication no. WO/2025/226787, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YI, Peng (c/o Joslin Diabetes CenterOne Joslin PlaceBoston, Massachusetts 02215), CLIFFORD, Christopher Everette (c/o Joslin Diabetes CenterOne Joslin PlaceBoston, MA 02215)

Abstract: This disclosure relates to stem cells lacking endoge...